Rheumatic Diseases

Rheumatic Diseases

Here: a primary care perspective on diagnosis of -- and care of patients with -- rheumatologic disorders.

Rheumatic Diseases

Macrophage activation syndrome, a devastating complication of some rheumatic conditions, shows pathologic similarities to a rare hereditary condition. Genetic studies imply that their similarities may be more than coincidental.

Polycystic ovary syndrome, “dermatoses of pregnancy,” systemic sclerosis, subacute cutaneous lupus erythematosus, gallbladder agenesis, sarcoidosis—a close look at medical problems seen frequently in women.

An eight-year study of more than 100 patients with giant cell arteritis reveals that for the majority of patients it is not an isolated episode. Relapses tend to occur within two years, usually as polymyalgia rheumatica or cranial symptoms.

A special six-part section on vasculitis, available for free in full text online for six months, focuses on pathogenesis, treatment strategies, and the need to reconsider mechanisms in defining the subtypes.

The link between fatigue and disease activity in inflammatory arthritis appears not to be as simple as previously assumed.

The FDA today announced that it is preparing to regulate laboratory tests developed and marketed within a single lab. This should lead eventually to more clarity about testing for diagnosis and treatment of rheumatic diseases.

Antiphospholipid syndrome involves both blood vessel damage and thrombosis. A new study reveals the molecular pathway that causes the former, and a drug that inhibits it.


Subscribe to Rheumatic Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.